NEW AWARD FOR UBLITUXIMAB-XIIY 150MG/6ML INJECTION (ANTI-CD20 ANTIBODIES WITH TG THERAPEUTICS. PERIOD OF PERFORMANCE JUNE 17, 2024 - JUNE 16, 2025 WITH FOUR ONE-YEAR OPTIONS.
$186,776,520
| Recipient | TG THERAPEUTICS INC UEI JKPZKD19WMD7 |
|---|---|
| Award ID | 36E79724D0024 |
| Award amount | $186,776,520 |
| Award type | — |
| Awarding agency | Department of Veterans Affairs — Department of Veterans Affairs |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Start date | Jun 17, 2024 |
| End date | — |
| Place of performance | — |
| Record updated | Sep 24, 2024 |
View the official award record
More awards won by TG THERAPEUTICS INC
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $250,000 · May 15, 2023
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids